Feb 23, 2026

Featuring an interview with Dr Terence Friedlander, including the following topics:

• Perioperative durvalumab with neoadjuvant chemotherapy: Health-related quality-of-life outcomes in the NIAGARA trial (0:00)
• Targeting HER2 in locally advanced or metastatic urothelial carcinoma (5:17)
• TROP2-targeted antibody-drug...

Feb 17, 2026

Featuring patient case presentations by Dr Fern Anari and Dr Catherine Fahey, with commentary from Dr Matthew D Galsky, including the following topics:

• Case: A man in his early 60s with urothelial bladder cancer (UBC) is found to have metastatic disease shortly after surgery (0:00)
• Case: A man in his late 70s...

Feb 5, 2026

Featuring an interview with Dr Terence Friedlander, including the following topics:

• Final analysis of the Phase III, open-label, randomized POTOMAC trial (0:00)
• KEYNOTE-905 trial: Perioperative enfortumab vedotin with pembrolizumab for muscle-invasive bladder cancer (MIBC) (5:25)
• The neoadjuvant gemcitabine...

Jul 23, 2025

Featuring perspectives from Prof Laurence Albiges and Dr Tian Zhang, including the following topics:

• Introduction: Adjuvant Immunotherapy for Localized Renal Cell Carcinoma (RCC) (0:00)
• Metastatic Clear Cell RCC — Faculty Presentation (9:22)
• Metastatic Clear Cell RCC — Survey Questions (20:24)
• Non-Clear Cell RCC...

Jul 10, 2025

Featuring perspectives from Dr Matthew D Galsky, Prof Andrea Necchi and Prof Thomas Powles, moderated by Dr Galsky, including the following topics:

• Introduction (0:00)
• Current and Future Management of Muscle-Invasive Bladder Cancer — Prof Powles (1:14)
• Novel Intravesical Therapies Under Evaluation for...